Meilan King Han, MD, a professor of internal medicine at the University of Michigan, discusses how her practice has altered patient care to adapt to the ongoing pandemic and challenges patients with ...
Trisha Parekh, DO, discusses her research on the impact of psychological stress on low-income patients with chronic obstructive pulmonary disease (COPD). The COVID-19 pandemic has brought social ...
How many people does Chronic Obstructive Pulmonary Disease (COPD) affect and what impact does it have on their lives? It’s a difficult number to estimate but it’s probably between four and six percent ...
Please can you give a brief introduction to Olodaterol? Olodaterol is a long-acting beta2-agonist (LABA) bronchodilator delivered via the Respimat ® inhaler. It is being investigated as a once daily ...
—Meilan Han, MD, MS, University of Michigan, discusses COPD screening and diagnosis--and why women with COPD sometimes seem invisible. Meilan Han, MD, MS, is Associate Professor of Medicine in the ...
COPD is a group of progressive lung diseases that includes emphysema and chronic bronchitis. Despite affecting an estimated 32 million people in the United States, as many as half are unaware they ...
Pulmonary rehabilitation (PR) is recommended in the management of people with chronic obstructive pulmonary disease (COPD), but referral to this service is low. Twelve general practitioners ...
People with COPD have a higher risk of developing pneumonia due to changes in their lung microbiome. Early detection and treatment could help reduce the risk of complications. Chronic obstructive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results